Clinical Trial Update: Weekly Single Fraction Hypofractionated Adjuvant Radiotherapy for Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating weekly single-fraction hypofractionated adjuvant radiotherapy for early stage breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Mona Salem | Conditions: Breast Cancer, Radiotherapy Side Effect | Phase 2 | Status: UNKNOWN